Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

NCT00061048 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

NIH

Sponsor class

Conditions

Acute T-Cell Leukemia-Lymphoma

Interventions

BIOLOGICAL: Alemtuzumab

Sponsor

National Cancer Institute (NCI)